Imagene AI Competitors and Similar CompaniesClear all
Imagene AI's competitors and similar companies include Ezra, Leadoptik, Freenome and Anixa Biosciences.
 Anixa Biosciences Anixa Biosciences (formerly known as ITUS Corporation) is a biotechnology company providing diagnostic and therapeutic solutions for the early detection of tumor-based cancers. | |||||
Founding Date | Founding Date 2020 | Founding Date 2018 | Founding Date 2020 | Founding Date 2014 | Founding Date 1982 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Tel Aviv-Yafo, IL HQ | Locations New York, US HQ Aventura, US Beverly Hills, US Great Neck, US Irvine, US Las Vegas, US Miami, US see more | Locations San Jose, US HQ | Locations South San Francisco, US HQ | Locations San Jose, US HQ |
Employees | Employees 323% decrease | Employees 913% increase | Employees 16 | Employees 4172% increase | Employees 7 |
Funding | |||||
Latest funding round | Latest funding round $ 18.5m (about 4 years ago) | Latest funding round $ 18m (about 6 years ago) | Latest funding round $ 6.6m (almost 3 years ago) | Latest funding round $ 270m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 21.5m | Total funding raised $ 22m | Total funding raised $ 6.6m | Total funding raised $ 507.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Ezra
HQ
New York, US
Employees
91↑ 3% increase
Ezra AI is a healthcare company developing early cancer detection technologies.
View company
Leadoptik
HQ
San Jose, US
Employees
16
Leadoptik is a technology company that develops an imaging platform.
View company
Freenome
HQ
South San Francisco, US
Employees
417↑ 2% increase
Freenome is a biotech company that develops blood tests to detect cancer.
View companyAnixa Biosciences
HQ
San Jose, US
Employees
7
Anixa Biosciences (formerly known as ITUS Corporation) is a biotechnology company providing diagnostic and therapeutic solutions for the early detection of tumor-based cancers.
View company